Skip to content
Telehealth Graded

Search Telehealth Graded

Use arrow keys or Tab to browse. Enter opens a result. Escape closes search.

Enter a name or topic to search.

State guide

Pennsylvania Medicaid and GLP-1s

If you're in Pennsylvania and Medical Assistance was paying for your Wegovy or Zepbound, it stopped on January 1, 2026. The same drugs are still covered for diabetes, sleep apnea and a handful of other diagnoses — with prior authorization. Here's what the state's own bulletin says, and what it means if you're now shopping cash-pay.

Every source on this page was read first-hand in September 2026, and each one below carries the date printed on the document itself.

1
document cited
7
sourced facts
1
primary source

What changed, and what the document says

  1. GLP-1s for weight loss

    Not covered

    Not covered as of January 1, 2026. Pennsylvania had covered them for weight loss since January 2023.

    “Effective January 1, 2026, drugs containing a GLP-1 receptor agonist will not be covered for the treatment of overweight and obesity.”

    Commonwealth of Pennsylvania, Department of Human Services, Office of Medical Assistance Programs — Medical Assistance Bulletin — November 24, 2025

  2. GLP-1s for other diagnoses

    Conditions apply

    Still covered, but every one of them now needs prior authorization first.

    “Drugs containing a GLP-1 receptor agonist will continue to be covered for all other medically accepted indications with a prior authorization.”

    Commonwealth of Pennsylvania, Department of Human Services, Office of Medical Assistance Programs — Medical Assistance Bulletin — November 24, 2025

  3. Saxenda

    Not covered

    Dropped completely — not just for weight loss. It's the only drug the bulletin singles out this way.

    “Saxenda (liraglutide) will no longer be covered for any indication.”

    Commonwealth of Pennsylvania, Department of Human Services, Office of Medical Assistance Programs — Medical Assistance Bulletin — November 24, 2025

  4. Non-GLP-1 weight drugs

    Covered

    Still covered, and the preferred ones skip prior authorization. Phentermine is the example the bulletin gives.

    “Obesity Treatment Agents that do not contain a GLP-1 receptor agonist will continue to be covered by the MA Program.”

    Commonwealth of Pennsylvania, Department of Human Services, Office of Medical Assistance Programs — Medical Assistance Bulletin — November 24, 2025

  5. Quantity limit

    Conditions apply

    One month per fill. That rules out the 90-day fills that make some cash-pay plans look cheap.

    “Prescriptions for GLP-1 Receptor Agonists will be limited to a one-month supply per fill.”

    Commonwealth of Pennsylvania, Department of Human Services, Office of Medical Assistance Programs — Medical Assistance Bulletin — November 24, 2025

  6. Why the state could do this

    Context

    Weight-loss drug coverage isn't something federal law requires of a state Medicaid program. Pennsylvania cites the statute in the bulletin itself.

    “Coverage of drugs for weight loss is an optional benefit for Medicaid programs. See 42 U.S.C. § 1396r-8(d)(2)(A).”

    Commonwealth of Pennsylvania, Department of Human Services, Office of Medical Assistance Programs — Medical Assistance Bulletin — November 24, 2025

  7. How long an approval lasts

    Context

    Six months for sleep apnea and for other non-diabetes diagnoses; twelve for diabetes.

    “For a GLP-1 Receptor Agonist for a diagnosis of diabetes, requests will be approved for up to 12 months.”

    Commonwealth of Pennsylvania, Department of Human Services, Office of Medical Assistance Programs — Medical Assistance Bulletin — November 24, 2025

Telehealth in Pennsylvania

Some providers pay us a commission when you sign up through our links, at no extra cost to you.

Which of these companies serve Pennsylvania?

Of the 284 companies we grade, 28 publish a list of the states they are licensed in. We checked 250 more and found no such list on any page we read; 6 we have not checked either way.

20 of those lists name Pennsylvania: Gala Health, Care Bare Rx, Vita Bella, TelePeptide, Levity, WePeptideRx, Ways2Well, TeleClinic, Tyde Wellness, Willow, VevaRx, Trimi, Enhance MD, HumeCare+, Rx.com, Mojoon, Peak Wellness, Sprout Health, Allara Health, and MEDvidi. That is a licensure claim each company makes about itself, not something we checked with a state board.

A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.

Coverage decides what you pay before cash does. See how state Medicaid programs cover GLP-1s and what a prior-authorization denial turns on.

Sources

Each document below was fetched and read on the date shown beside it, which is the date printed on the document — not always the date in its web address. All of them were read in September 2026.

Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.